Search research articles
Contact Us
Filters
Showing results (171-180 of 546) with videos related to
Page
of 55
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 19, 2023
Toward Single-Time-Point Image-Based Dosimetry of <sup>177</sup>Lu-PSMA-617 Therapy
Julia Brosch-Lenz, Astrid Delker, Friederike Völter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 27, 2024
Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-I&T Therapy
Sandra Resch, Sibylle I Ziegler, Gabriel Sheikh, et al.
Neuro-Oncology
|
October 11, 2017
Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma
Bogdana Suchorska, Armin Giese, Annamaria Biczok, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 8, 2003
Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride
Gerhard Gründer, Thomas Siessmeier, Markus Piel, et al.
Bioconjugate Chemistry
|
January 10, 2009
Kit-like 18F-labeling of proteins: synthesis of 4-(di-tert-butyl[18F]fluorosilyl)benzenethiol (Si[18F]FA-SH) labeled rat serum albumin for blood pool imaging with PET
Björn Wängler, Gabriele Quandt, Ljuba Iovkova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2009
18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease
Axel Rominger, Tobias Saam, Sarah Wolpers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 7, 2011
Treatment with octreotide does not reduce tumor uptake of (68)Ga-DOTATATE as measured by PET/CT in patients with neuroendocrine tumors
Alexander R Haug, Axel Rominger, Mona Mustafa, et al.
Journal of Medicinal Chemistry
|
May 1, 2014
Shuttle-cargo fusion molecules of transport peptides and the hD2/3 receptor antagonist fallypride: a feasible approach to preserve ligand-receptor binding?
Carmen Wängler, Shafinaz Chowdhury, Georg Höfner, et al.
Animals : an Open Access Journal From MDPI
|
August 2, 2023
Longitudinal Studies on Alzheimer Disease Mouse Models with Multiple Tracer PET/CT: Application of Reduction and Refinement Principles in Daily Practice to Safeguard Animal Welfare during Progressive Aging
Giovanna Palumbo, Lea Helena Kunze, Rosel Oos, et al.
Journal of Alzheimer'S Disease : JAD
|
July 17, 2018
Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms
Matthias Brendel, Julia Sauerbeck, Sonja Greven, et al.
Page
of 55
Search research articles
Search
Showing results (171-180 of 546) with videos related to
Sort By:
Page
of 55
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 19, 2023
Toward Single-Time-Point Image-Based Dosimetry of <sup>177</sup>Lu-PSMA-617 Therapy
Julia Brosch-Lenz, Astrid Delker, Friederike Völter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 27, 2024
Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-I&T Therapy
Sandra Resch, Sibylle I Ziegler, Gabriel Sheikh, et al.
Neuro-Oncology
|
October 11, 2017
Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma
Bogdana Suchorska, Armin Giese, Annamaria Biczok, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 8, 2003
Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride
Gerhard Gründer, Thomas Siessmeier, Markus Piel, et al.
Bioconjugate Chemistry
|
January 10, 2009
Kit-like 18F-labeling of proteins: synthesis of 4-(di-tert-butyl[18F]fluorosilyl)benzenethiol (Si[18F]FA-SH) labeled rat serum albumin for blood pool imaging with PET
Björn Wängler, Gabriele Quandt, Ljuba Iovkova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2009
18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease
Axel Rominger, Tobias Saam, Sarah Wolpers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 7, 2011
Treatment with octreotide does not reduce tumor uptake of (68)Ga-DOTATATE as measured by PET/CT in patients with neuroendocrine tumors
Alexander R Haug, Axel Rominger, Mona Mustafa, et al.
Journal of Medicinal Chemistry
|
May 1, 2014
Shuttle-cargo fusion molecules of transport peptides and the hD2/3 receptor antagonist fallypride: a feasible approach to preserve ligand-receptor binding?
Carmen Wängler, Shafinaz Chowdhury, Georg Höfner, et al.
Animals : an Open Access Journal From MDPI
|
August 2, 2023
Longitudinal Studies on Alzheimer Disease Mouse Models with Multiple Tracer PET/CT: Application of Reduction and Refinement Principles in Daily Practice to Safeguard Animal Welfare during Progressive Aging
Giovanna Palumbo, Lea Helena Kunze, Rosel Oos, et al.
Journal of Alzheimer'S Disease : JAD
|
July 17, 2018
Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms
Matthias Brendel, Julia Sauerbeck, Sonja Greven, et al.
Page
of 55